CA-VERIMATRIX
20.4.2022 17:47:11 CEST | Business Wire | Press release
Regulatory News:
Verimatrix , (Euronext Paris: VMX) (Paris:VMX), the leader in powering the modern connected world with people-centered security, today announced that Megacable , one of Mexico’s largest telecommunications companies, selected a suite of Verimatrix products and technologies to fortify its enterprise defenses; Verimatrix XTD (Extended Threat Defense), Streamkeeper Watermarking , Streamkeeper Edge Authenticator and App Shield .
Megacable, the first company in Mexico to offer quadruple-play services (cable television, broadband internet, fixed telephony and mobile telephony), has millions of subscribers using the media company’s apps running on unmanaged devices. The company was well aware that extended endpoints at the app level could be weaponized at any time by attackers to attack their enterprise defenses, and they wanted to find a way to expand their defense beyond the traditional perimeter. Additionally, it’s no secret that the media & entertainment industry is seeing a rise in industrial-scale piracy attacks on content distribution networks, and they selected Verimatrix specifically for its distinguished reputation in both threat defense and anti-piracy.
Megacable products set to use Verimatrix threat defense and anti-piracy solutions include the Xview+ app, Android TV set-top boxes, select Megacable.com.mx payment/financial services, as well as other internal Megacable apps.
Hackers are continually looking for new ways to infiltrate enterprise security walls and Verimatrix XTD consistently identifies and closes vulnerabilities. Verimatrix XTD is an enterprise SaaS solution that will monitor Megacable’s mobile apps and devices connected to their cloud services.
Verimatrix XTD’s features include:
- Shielding Apps – With self-defending mobile application shielding, Verimatrix provides organizations with layers of protections such as obfuscation, environmental checks and anti-tamper, plus 24/7 monitoring with immediate detection when an app is under attack with remote shut-down capability.
- Unmanaged Device Telemetry – Protection from unmanaged devices at the endpoint, such as set-top box receivers, IoT and medical devices, by gaining real-time, continuous threat intelligence utilizing Verimatrix’s zero-code telemetry technology.
- Monitoring and Early Detection – Better understand the threat profile of your installed base of users, and drill down into the risk score of an individual app instance, with real-time notifications of high-risk events to uncover hidden dangers in your enterprise security wall.
- Attack Pattern Detection and Prediction – Comprehensive, predictive analysis of cyber threats based on large data sets, artificial intelligence (AI) and machine learning (ML), to recognize patterns, making future predictions to benefit the enterprise.
Having used Verimatrix IPTV and DVB Hybrid content security solutions since 2012, Megacable’s work with Verimatrix is also expanded with the deployment of Watermarking and Edge Authenticator anti-piracy solutions. The unique deployment of Streamkeeper zero-code injection technology into select Megacable set-top boxes is a first for both companies. The process will protect access to the Content Security Network (CDN) without the need for cumbersome, time consuming or expensive integrations, meeting stringent requirements from major studios that require it for 4K Ultra HD content. Megacable may add additional Verimatrix Streamkeeper services to its portfolio of anti-piracy countermeasures in the future.
“Megacable already enjoys robust network security, but by adding Verimatrix XTD and Streamkeeper anti-piracy technologies, we’re creating an even more formible security posture for our company, our content and our customers,” said Gerardo Seifert Arriola, Chief Marketing Officer at Megacable. “We’re pleased to continue working with Verimatrix to provide an excellent user experience while also deploying the latest in security technology to maintain our stance as the regional leader in our industry.”
“Megacable has taken a bold step forward by adding threat defense and anti-piracy technology to their enterprise security stack,” said Asaf Ashkenazi , Chief Operating Officer and President at Verimatrix. “Megacable is now our largest customer to date to commit to deploying Verimatrix Streamkeeper and Verimatrix XTD solutions. The alliance underscores our goal to provide proactive cybersecurity and anti-piracy countermeasures that fortify operators against threats of today and the unforeseen dangers of tomorrow. We’re pleased to continue working with Megacable to provide unique and innovative solutions that boost protections and also help ensure exceptional user experiences no matter how content is accessed.”
About Megacable
Megacable Holdings S.A.B. de C.V. (BMV: MEGA.CPO) is one of the largest telecommunications companies in Mexico and Latin America. It carries out operations in 28 states of the country, with a presence in 400 locations. As of December 31, 2021, it has about 4.2 million unique subscribers, including more than 3.8 million internet subscribers, more than 3.5 million video users and more than 3 million fixed telephony customers. It offers its services through a network of nearly 66,000 kilometers, covering more than 9.5 million homes. Visit www.megacable.com.mx
.
About Verimatrix
Verimatrix (Euronext Paris: VMX) helps power the modern connected world with security made for people. We protect digital content, applications, and devices with intuitive, people-centered and frictionless security. Leading brands turn to Verimatrix to secure everything from premium movies and live streaming sports, to sensitive financial and healthcare data, to mission-critical mobile applications. We enable the trusted connections our customers depend on to deliver compelling content and experiences to millions of consumers around the world. Verimatrix helps partners get to market faster, scale easily, protect valuable revenue streams, and win new business. Visit www.verimatrix.com
.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220420005732/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces 24-Week Long-Term Data from Phase 3 TRuE-AD4 Trial of Opzelura® (ruxolitinib) Cream in Adults with Moderate Atopic Dermatitis7.5.2026 14:50:00 CEST | Press release
First presentation of Week 24 results from TRuE-AD4 study in adults with moderate atopic dermatitis (AD) who had an inadequate response, intolerance or contraindication to topical corticosteroids (TCSs) and topical calcineurin inhibitors (TCIs)at the 2026 EADV SymposiumThe vast majority of patients achieving EASI50 at Week 8 and continuing double-blind, as needed treatment with Opzelura® (ruxolitinib) cream through Week 24 demonstrated disease control, with 84.3% achieving EASI75 (a ≥75% improvement in the Eczema Area and Severity Index score from baseline) and 70.6% achieving IGA-TS (Investigator’s Global Assessment Treatment Success)Data support Type-II variation application submitted for ruxolitinib cream 1.5% for the treatment of adults with moderate AD in the European Union (EU), feedback expected in 1H 2026 Incyte (Nasdaq:INCY) today announced final 24-week data from the Phase 3 TRuE-AD4 study evaluating the efficacy and safety of Opzelura® (ruxolitinib) cream in adults with mode
Rapid Medical™’s TIGERTRIEVER™ 13 Demonstrates Promising 90-Day Outcomes in DISTALS Trial, Reinforcing Pivotal Safety and Efficacy Findings7.5.2026 14:03:00 CEST | Press release
Full data presented at ESOC 2026 further strengthen the clinical evidence supporting TIGERTRIEVER™ 13 for the treatment of distal vessel occlusion stroke — a segment representing nearly half of all ischemic strokes Rapid Medical™, a leading developer of advanced stroke treatment devices, today announced full results from the DISTALS randomized clinical trial, presented at the 11th European Stroke Organisation Conference (ESOC) in Maastricht, Netherlands, showing that TIGERTRIEVER™ 13 can safely restore blood flow to the brain and may improve clinical outcomes in patients with distal and medium vessel occlusion (DMVO) stroke. These findings build on earlier results showing a threefold improvement in restoring blood flow compared with medical management alone (p<0.0001), with no cases of serious brain bleeding observed in the treatment group. “These results show we can now safely restore blood flow and suggest this will make a meaningful difference for the right patients,” said Jeffrey L
2 Million Downloads in Six Months: Tabelog’s Multilingual App Solves Critical Dining Pain Points for Travelers to Japan7.5.2026 14:00:00 CEST | Press release
“Eat Where Locals Eat” Making authentic Japanese dining experiences accessible to global travelers through instant reservations at over 70,000 restaurants nationwide. Tabelog (https://tabelog.com/en/), one of Japan’s largest (*1) restaurant search and reservation services operated by Kakaku.com, Inc., has announced that its multilingual smartphone app (iOS/Android) for travelers visiting Japan has reached 2 million downloads (*2). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260507560248/en/ 2M+ Downloads in 6 Months. The app also ranked #1 in downloads among Restaurant Search Apps in Japan for International Travelers (*3) in Taiwan, Hong Kong, South Korea, and the U.S., reflecting its immense popularity among global visitors. Download URL: https://tabelog-tourists.onelink.me/3eEh/iqkkho9r The Trusted Choice for Global Travelers: Solving Two Major Dining Pain Points in Japan For years, international visitors to Japan have
Altasciences and Certara Announce Strategic Partnership to Accelerate Early Drug Development7.5.2026 14:00:00 CEST | Press release
Altasciences, a fully integrated drug development solution company, andCertara (Nasdaq: CERT), a global leader in model-informed drug development (MIDD), today announced a strategic partnership to accelerate early-phase development programs. Fewer than half of preclinical drug candidates successfully reach first-in-human trials. Failures are driven by toxicity, poor pharmacokinetics, lack of efficacy, and challenges translating results from animals to humans. Many of these risks can be mitigated through a fully integrated model-informed drug development approach. Building on Altasciences’ Acceleration Platform, the integration of Certara’s strategic drug development services and biosimulation technology enables sponsors to establish proof of mechanism earlier, design more efficient studies, and make informed go/no-go decisions with greater confidence. By embedding modeling insights and digital workflows directly into development execution, study designs are optimized, dosing strategies
FIFA and Fanatics Expand Wide-Ranging Relationship to Include Historic Exclusive Collectibles Agreement (Trading Cards, Stickers and Trading Card Games)7.5.2026 13:00:00 CEST | Press release
Partnership includes FIFA tournaments and events from 2031Agreement encompasses both physical and digital collectibles, and for the first time brings the player jersey patch program to international footballPre-match press conferences for the FIFA World Cup Final to take place at Fanatics Fest on Friday, 17 July 2026 In a landmark agreement expanding their already successful wide-ranging commercial relationship, FIFA and Fanatics have signed a long-term, exclusive collectibles licensing deal that features trading cards, stickers, and trading card games. The agreement, which will begin in full in 2031, covers both physical and digital collectibles. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260507105628/en/ An example of the product innovations that will be brought to fans under this new partnership is the highly sought-after player jersey patch program, including debut patches, which will be inserted into football tradin
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
